萬科A(000002.SZ):擬出資5億元與深鐵集團共同投資成立合資公司
格隆匯 6 月 29日丨萬科A(000002.SZ)公佈,萬科企業股份有限公司(以下簡稱“公司”或“萬科”)與深圳市地鐵集團有限公司(以下簡稱“深鐵集團”)於2020年6月29日簽署《深圳市地鐵集團有限公司與萬科企業股份有限公司成立合資公司之備忘錄》,擬共同投資成立合資公司。合資公司註冊資本暫定為人民幣10億元,其中,萬科認繳出資人民幣5億元,佔註冊資本的50%;深鐵集團認繳出資人民幣5億元,佔註冊資本的50%。截至本公告之日,深鐵集團持有公司27.91%的股份,按照《深圳證券交易所股票上市規則》等規定,本次交易構成公司的關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.